Fig. 1From: Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapySchematic representation of amino acids representing immunogenic epitopes against anti-NY-ESO-1 antibody, CD4+ and CD8+ T cell responses. Naturally occurring anti-NY-ESO-1 antibodies are mostly mapping to soluble N-terminus region while the cellular responses are mapping to the C-terminus region [139]Back to article page